Literature DB >> 10196355

Packaging cell lines for simian foamy virus type 1 vectors.

M Wu1, A Mergia.   

Abstract

Foamy viruses are nonpathogenic retroviruses that offer several unique opportunities for gene transfer in various cell types from different species. We have previously demonstrated the utility of simian foamy virus type 1 (SFV-1) as a vector system by transient expression assay (M. Wu et al., J. Virol. 72:3451-3454, 1998). In this report, we describe the first stable packaging cell lines for foamy virus vectors based on SFV-1. We developed two packaging cell lines in which the helper DNA is placed under the control of either a constitutive cytomegalovirus (CMV) immediate-early gene or inducible tetracycline promoter for expression. Although the constitutive packaging expressing cell line had a higher copy number of packaging DNA, the inducible packaging cell line produced four times more vector particles. This result suggested that the structural gene products in the constitutively expressing packaging cell line were expressed at a level that is not toxic to the cells, and thus vector production was reduced. The SFV-1 vector in the presence of vesicular stomatitis virus envelope protein G (VSV-G) produced an insignificant level of transduction, indicating that foamy viruses could not be pseudotyped with VSV-G to generate high-titer vectors. The availability of stable packaging cell lines represents a step toward the use of an SFV-1 vector delivery system that will allow scaled-up production of vector stocks for gene therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196355      PMCID: PMC104344     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Regulation of foamy virus gene expression.

Authors:  A Rethwilm
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

2.  In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus.

Authors:  J A Mikovits; P M Hoffman; A Rethwilm; F W Ruscetti
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  Transduction of hematopoietic cells by foamy virus vectors.

Authors:  R K Hirata; A D Miller; R G Andrews; D W Russell
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

4.  The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses.

Authors:  R K Naviaux; E Costanzi; M Haas; I M Verma
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Cell tropism of the simian foamy virus type 1 (SFV-1).

Authors:  A Mergia; N J Leung; J Blackwell
Journal:  J Med Primatol       Date:  1996-01       Impact factor: 0.667

6.  Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step.

Authors:  A Saïb; F Puvion-Dutilleul; M Schmid; J Périès; H de Thé
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line.

Authors:  P Corbeau; G Kraus; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G.

Authors:  R K Akkina; R M Walton; M L Chen; Q X Li; V Planelles; I S Chen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Foamy virus vectors.

Authors:  D W Russell; A D Miller
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Replicating foamy virus-based vectors directing high level expression of foreign genes.

Authors:  M Schmidt; A Rethwilm
Journal:  Virology       Date:  1995-06-20       Impact factor: 3.616

View more
  5 in total

1.  Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging.

Authors:  M Heinkelein; J Thurow; M Dressler; H Imrich; D Neumann-Haefelin; M O McClure; A Rethwilm
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Historical perspective of foamy virus epidemiology and infection.

Authors:  C D Meiering; M L Linial
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer.

Authors:  Nicole Armbruster; Jennifer Krieg; Manuel Weißenberger; Carsten Scheller; Andre F Steinert
Journal:  Front Pharmacol       Date:  2017-05-09       Impact factor: 5.810

4.  Efficient production of inhibitor-free foamy virus glycoprotein-containing retroviral vectors by proteoglycan-deficient packaging cells.

Authors:  Clara Marie Munz; Henriette Kreher; Alexander Erdbeer; Stefanie Richter; Dana Westphal; Buqing Yi; Rayk Behrendt; Nicole Stanke; Fabian Lindel; Dirk Lindemann
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-01       Impact factor: 5.849

Review 5.  Progresses towards safe and efficient gene therapy vectors.

Authors:  Sergiu Chira; Carlo S Jackson; Iulian Oprea; Ferhat Ozturk; Michael S Pepper; Iulia Diaconu; Cornelia Braicu; Lajos-Zsolt Raduly; George A Calin; Ioana Berindan-Neagoe
Journal:  Oncotarget       Date:  2015-10-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.